Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
9.82
+0.23 (2.40%)
At close: Nov 13, 2026, 4:00 PM EST
9.48
-0.34 (-3.43%)
After-hours: Nov 13, 2026, 7:30 PM EST
Sutro Biopharma Employees
Sutro Biopharma had 129 employees as of September 30, 2026. The number of employees decreased by 49 or 27.53% compared to the same quarter last year. That makes Sutro Biopharma the 29,934th largest employer in the world and 3,799th in the United States.
Employees
129
Change (1Y)
-49
Growth (1Y)
-27.53%
Revenue / Employee
$349,667
Profits / Employee
-$1,203,628
Market Cap
163.03M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2026 | 129 | -49 | -27.53% |
| Jun 30, 2026 | 128 | -116 | -47.54% |
| Mar 31, 2026 | 133 | -136 | -50.56% |
| Dec 31, 2025 | 137 | -173 | -55.81% |
| Sep 30, 2025 | 178 | -128 | -41.83% |
| Jun 30, 2025 | 244 | -60 | -19.74% |
| Mar 31, 2025 | 269 | -31 | -10.33% |
| Dec 31, 2024 | 310 | 8 | 2.65% |
| Sep 30, 2024 | 306 | 8 | 2.68% |
| Jun 30, 2024 | 304 | 7 | 2.36% |
| Mar 31, 2024 | 300 | 8 | 2.74% |
| Dec 31, 2023 | 302 | 24 | 8.63% |
| Sep 30, 2023 | 298 | 39 | 15.06% |
| Jun 30, 2023 | 297 | 55 | 22.73% |
| Mar 31, 2023 | 292 | 58 | 24.79% |
| Dec 31, 2022 | 278 | 54 | 24.11% |
| Sep 30, 2022 | 259 | 41 | 18.81% |
| Jun 30, 2022 | 242 | 38 | 18.63% |
| Mar 31, 2022 | 234 | 39 | 20.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Fate Therapeutics | 161 |
| Invivyd | 122 |
| Zentalis Pharmaceuticals | 106 |
| enGene Therapeutics | 82 |
| Upstream Bio | 75 |
| Sionna Therapeutics | 59 |
| Protara Therapeutics | 46 |
STRO News
- 2 days ago - Sutro Biopharma price target lowered to $25 from $60 at Wedbush - TheFly
- 2 days ago - Sutro Biopharma price target raised to $57 from $56 at Barclays - TheFly
- 2 days ago - Sutro Biopharma reports Q3 EPS ($1.90), consensus ($1.96) - TheFly
- 2 days ago - Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 2 days ago - Sutro Biopharma Earnings release: Q3 2026 - Filings
- 2 days ago - Sutro Biopharma Quarterly report: Q3 2026 - Filings
- 3 days ago - Sutro Biopharma Slides: Corporate presentation - Filings
- 4 days ago - Sutro Biopharma Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts